Saccharopine Dehydrogenase (NAD+, L-glutamate-forming)
Saccharopine Dehydrogenase (NAD+, L-glutamate-forming) is an enzyme that plays a crucial role in the lysine degradation pathway, specifically in the amino acid metabolism. This enzyme catalyzes the sixth step of the lysine degradation via the aminoadipic acid pathway, which is essential for the catabolism of lysine into end products that can be utilized in the citric acid cycle for energy production. The reaction catalyzed by saccharopine dehydrogenase involves the conversion of saccharopine into L-glutamate and alpha-aminoadipate semialdehyde, with the concomitant reduction of NAD+ to NADH.
Function[edit | edit source]
Saccharopine dehydrogenase is bifunctional and exists in two isoforms, which are involved in both the synthesis and degradation of saccharopine. In the lysine degradation pathway, it facilitates the breakdown of lysine, contributing to the maintenance of nitrogen balance within the cell and the production of energy. The enzyme's activity is crucial for the proper metabolism of lysine, and disruptions in this pathway can lead to metabolic disorders.
Genetics[edit | edit source]
The gene encoding saccharopine dehydrogenase is located on chromosome 1 in humans. Mutations in this gene can lead to lysine intolerance and are associated with a rare metabolic disorder known as hyperlysinemia type II, characterized by an accumulation of lysine and saccharopine in the blood and urine. This condition can result in various symptoms, including developmental delay, seizures, and cognitive impairment.
Structure[edit | edit source]
Saccharopine dehydrogenase is a mitochondrial enzyme that is composed of multiple domains, including a binding domain for NAD+ and a catalytic domain for the conversion of substrates. The enzyme's structure is essential for its function, as alterations in its conformation can affect its activity and stability.
Clinical Significance[edit | edit source]
Understanding the function and structure of saccharopine dehydrogenase is important for the diagnosis and treatment of metabolic disorders related to lysine degradation. Inhibitors or activators of this enzyme could potentially be used to regulate lysine levels in patients with metabolic disorders. Furthermore, research into saccharopine dehydrogenase can provide insights into the broader mechanisms of amino acid metabolism and its role in human health and disease.
Research Directions[edit | edit source]
Current research on saccharopine dehydrogenase focuses on elucidating its detailed structure-function relationships, understanding the genetic basis of disorders associated with its dysfunction, and exploring its potential as a target for therapeutic intervention in metabolic diseases. Additionally, studies are investigating the enzyme's role in aging and neurodegenerative diseases, given its involvement in amino acid metabolism and energy production.
This article is a stub. You can help WikiMD by registering to expand it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD